Pfizer says LITFULO improved vitiligo repigmentation
Pfizer said LITFULO significantly improved facial and total body repigmentation in patients with nonsegmental vitiligo.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Pfizer said LITFULO significantly improved facial and total body repigmentation in patients with nonsegmental vitiligo.